FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £20.00m
- £20.14m
- £1.97m
RCS - Fusion Antibodies - Expansion to OptiMAL collaboration agreement
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementRCS - Fusion Antibodies - Launch of New Interactive Investor Hub
AnnouncementREG - Fusion Antibodies - Trading update
AnnouncementREG - Fusion Antibodies - New contract with existing client
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Year-end trading statement
AnnouncementREG - Fusion Antibodies - Change of auditor
AnnouncementREG - Fusion Antibodies - Contract to develop a bespoke OptiPhage library
AnnouncementREG - Fusion Antibodies - Block admission six monthly return
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 07/03/2024
AnnouncementREG - Fusion Antibodies - Result of General Meeting and Total Voting Rights
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - Fusion Antibodies - First purchase order under MSA
AnnouncementREG - AIM - AIM Notice - 19/02/2024
Announcement